DOI:
10.1055/s-00000019
Fortschritte der Neurologie · Psychiatrie
LinksClose Window
References
Dodick DW, Turkel CC, DeGryse RE et al.
OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.
Headache 2010;
50: 921-936
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.